Current Diabetes Reports

, Volume 12, Issue 4, pp 325–328

Cancer Risk in Type 2 Diabetes

Invited Commentary

DOI: 10.1007/s11892-012-0277-4

Cite this article as:
Kong, A.P.S. & Chan, J.C.N. Curr Diab Rep (2012) 12: 325. doi:10.1007/s11892-012-0277-4

Keywords

Diabetes Cancer Anti-diabetic drugs 

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of Medicine and Therapeutics, The Chinese University of Hong KongPrince of Wales HospitalHong KongChina
  2. 2.Li Ka Shing Institute of Health SciencesThe Chinese University of Hong KongHong KongChina
  3. 3.Hong Kong Institute of Diabetes and ObesityThe Chinese University of Hong KongHong KongChina

Personalised recommendations